Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claus Johansen

Showing results (61-70 of 95) with videos related to

Pageof 10
Sort By:
Plos One|September 29, 2022
Global circRNA expression changes predate clinical and histological improvements of psoriasis patients upon secukinumab treatmentSabine Seeler, Liviu-Ionut Moldovan, Trine Bertelsen, et al.
Experimental Dermatology|March 18, 2014
Interleukin 20 protein locates to distinct mononuclear cells in psoriatic skinRikke Bech, Kristian Otkjaer, Svend Birkelund, et al.
The Journal of Investigative Dermatology|May 15, 2007
Dimethylfumarate specifically inhibits the mitogen and stress-activated kinases 1 and 2 (MSK1/2): possible role for its anti-psoriatic effectBorbala Gesser, Claus Johansen, Mads K Rasmussen, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 14, 2015
IκBζ is a key driver in the development of psoriasisClaus Johansen, Maike Mose, Pernille Ommen, et al.
BMC Immunology|November 20, 2013
Anti-inflammatory effect of a retrovirus-derived immunosuppressive peptide in mouse modelsMartin Tolstrup, Claus Johansen, Lars Toft, et al.
Acta Dermato-Venereologica|March 13, 2025
Systemic Targeted Therapies in Patients with Relapsed/Refractory Advanced Stage Cutaneous T-cell Lymphoma: A Real-world Single-centre Case SeriesSigne Hedebo, Martin B Pedersen, Lise M Lindahl, et al.
Immunohorizons|November 26, 2020
IL-37 Expression Is Downregulated in Lesional Psoriasis SkinKirsten Rønholt, Ane Langkilde-Lauesen Nielsen, Claus Johansen, et al.
Journal of Inflammation Research|January 2, 2018
Protein phosphatase 2Cδ/Wip1 regulates phospho-p90RSK2 activity in lesional psoriatic skinMads K Rasmussen, Jakob Nielsen, Rasmus B Kjellerup, et al.
Experimental Dermatology|January 22, 2017
Langerhans cell markers CD1a and CD207 are the most rapidly responding genes in lesional psoriatic skin following adalimumab treatmentLine Raaby, Cecilia Rosada, Ane Langkilde, et al.
International Journal of Molecular Sciences|February 13, 2026
IL-17 Cytokines Induce IκBζ in Dermal Fibroblasts to Promote Pro-Inflammatory Gene Expression in PsoriasisLejla Svraka, Anna Skarnvad Andersen, Toke Touborg, et al.
Pageof 10

Showing results (61-70 of 95) with videos related to

Sort By:
Pageof 10
Plos One|September 29, 2022
Global circRNA expression changes predate clinical and histological improvements of psoriasis patients upon secukinumab treatmentSabine Seeler, Liviu-Ionut Moldovan, Trine Bertelsen, et al.
Experimental Dermatology|March 18, 2014
Interleukin 20 protein locates to distinct mononuclear cells in psoriatic skinRikke Bech, Kristian Otkjaer, Svend Birkelund, et al.
The Journal of Investigative Dermatology|May 15, 2007
Dimethylfumarate specifically inhibits the mitogen and stress-activated kinases 1 and 2 (MSK1/2): possible role for its anti-psoriatic effectBorbala Gesser, Claus Johansen, Mads K Rasmussen, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 14, 2015
IκBζ is a key driver in the development of psoriasisClaus Johansen, Maike Mose, Pernille Ommen, et al.
BMC Immunology|November 20, 2013
Anti-inflammatory effect of a retrovirus-derived immunosuppressive peptide in mouse modelsMartin Tolstrup, Claus Johansen, Lars Toft, et al.
Acta Dermato-Venereologica|March 13, 2025
Systemic Targeted Therapies in Patients with Relapsed/Refractory Advanced Stage Cutaneous T-cell Lymphoma: A Real-world Single-centre Case SeriesSigne Hedebo, Martin B Pedersen, Lise M Lindahl, et al.
Immunohorizons|November 26, 2020
IL-37 Expression Is Downregulated in Lesional Psoriasis SkinKirsten Rønholt, Ane Langkilde-Lauesen Nielsen, Claus Johansen, et al.
Journal of Inflammation Research|January 2, 2018
Protein phosphatase 2Cδ/Wip1 regulates phospho-p90RSK2 activity in lesional psoriatic skinMads K Rasmussen, Jakob Nielsen, Rasmus B Kjellerup, et al.
Experimental Dermatology|January 22, 2017
Langerhans cell markers CD1a and CD207 are the most rapidly responding genes in lesional psoriatic skin following adalimumab treatmentLine Raaby, Cecilia Rosada, Ane Langkilde, et al.
International Journal of Molecular Sciences|February 13, 2026
IL-17 Cytokines Induce IκBζ in Dermal Fibroblasts to Promote Pro-Inflammatory Gene Expression in PsoriasisLejla Svraka, Anna Skarnvad Andersen, Toke Touborg, et al.
Pageof 10